Related Experiment Video
Updated: Jun 21, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Mapping alternative splicing events in colorectal cancer
Yifeng Zheng1, Guoqiang Zhong1, Qiuyu Song1
1Department of Gastroenterology; Guangdong Provincial Key Laboratory of Major Obstetric Diseases; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Aberrant alternative splicing (AS) events are implicated in colorectal cancer (CRC). This study identified 14,314 AS events in CRC, revealing specific AS roles in oncogenes like CDK4, offering targets for novel therapies.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Aberrant gene splicing is linked to colorectal cancer (CRC) development and progression.
- Understanding alternative splicing (AS) event types and their functional impact in CRC is crucial but remains under investigation.
Purpose of the Study:
- To comprehensively map significant alternative splicing (AS) events in colorectal cancer (CRC).
- To investigate the functional roles of identified AS events in key CRC-associated genes and their implications for targeted therapy.
Main Methods:
- Analysis of a public RNA-sequencing database (GSE138202) comparing CRC patients and healthy individuals.
- Identification and characterization of significant alternative splicing (AS) events.
- Functional analysis of AS events in key genes, including splicing factors, microRNAs, and oncogenes.
Main Results:
- Identified 14,314 significant alternative splicing (AS) events in colorectal cancer (CRC) patients.
- Observed diverse AS event types in key CRC-associated genes, including oncogenes.
- Demonstrated that exon 2 skipping in the oncogene CDK4 enhances cell migration and inhibits proliferation in CRC by affecting cell cycle regulation.
Conclusions:
- Alternative splicing (AS) plays a significant role in regulating colorectal cancer (CRC) progression.
- Specific AS events, such as those in CDK4, offer potential therapeutic targets for CRC.
- Findings provide a theoretical basis for developing targeted splicing therapies for colorectal cancer (CRC).
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

